Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METHYLENE BLUE vs METHYLPREDNISOLONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

METHYLENE BLUE vs METHYLPREDNISOLONE: Safety Overview

Metric METHYLENE BLUE METHYLPREDNISOLONE
Total FAERS Reports 846 63,857
Deaths Reported 165 12,828
Death Rate 19.5% 20.1%
Hospitalizations 536 26,552
Average Patient Age 48.0 yrs 46.7 yrs
% Female Patients 49.8% 55.6%
FDA Approval Date Apr 8, 2016 Approved Prior to Jan 1, 1982
Manufacturer Zydus Pharmaceuticals USA Inc. Asclemed USA, Inc.
Route INTRAVENOUS INTRA-ARTICULAR
Marketing Status Prescription Prescription